Gilead Sciences notched “fine” sales for the first quarter but the biopharma promised more to come. Gilead reported ...
GSK says it is owed a portion of Pfizer and BioNTech’s Covid-19 vaccine sales in the latest patent suit filed against the ...
Sage Therapeutics is doubling down on the “blockbuster potential” of its postpartum depression drug Zurzuvae, ...
AstraZeneca put the spotlight on its near-20% revenue growth during first-quarter earnings, driven in part by its success in ...
As part of its sweeping $1.5 billion cost-cutting measure, Bristol Myers Squibb is culling “about 12” programs from its ...
Merck KGaA is allocating over €300 million ($321.8 million) to build a new research building at its headquarters in Darmstadt ...
Regeneron is expanding its genetic medicine efforts and will work with California startup Mammoth Biosciences on gene-editing ...
Walgreens said Thursday it’s getting into cell and gene therapy pharmacy services and bringing its specialty pharmacy under a new name as it navigates the future of its business. In addition to ...
UnitedHealth Group’s Optum is shutting down its virtual care business, Endpoints News has learned. Known as Optum Virtual ...
Roche on Wednesday morning said it has “minor exposure” from the Biosecure Act, adding that it is making strides in China’s ...
Flindr Therapeutics has secured €20 million ($21 million) in a Series A raise aimed at advancing its lead program through an ...
After hitting a speed bump in its first attempt at developing a gene therapy for Friedreich’s ataxia, Astellas is ready to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback